Akouos Inc. (AKUS) is a Specialty Chemicals company listed on NASDAQ. There were no new wire items for AKUS in the last 30 days. The most recent was published Feb 14, 2023.

Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. The company is also developing AK-CLRN1 for the auditory manifestations of Usher syndrome 3A, or USH3A; and AK-antiVEGF for vestibular schwannoma. In addition, its precision genetic medicine platform addresses hearing loss related to genes needed for supporting cell function. Akouos, Inc. was incorporated in 2016 and is based in Boston, Massachusetts.

Latest news

25 items

AKUS FAQ

8 questions
  • What does Akouos Inc. do?
    Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. The company is also developing AK-CLRN1 for the auditory manifestations of Usher syndrome 3A, or USH3A; and AK-antiVEGF for vestibular schwannoma. In addition, its precision genetic...
  • What is the latest news on AKUS?
    Quantisnow has not tracked any new filings, ratings or press releases for AKUS in the last 30 days. The most recent wire item was published on February 14, 2023.
  • Where does AKUS stock trade?
    Akouos Inc. (AKUS) is listed on NASDAQ.
  • What sector and industry is AKUS in?
    Akouos Inc. operates in the Consumer Discretionary sector, Specialty Chemicals industry.
  • When did Akouos Inc. go public?
    Akouos Inc. (AKUS) completed its IPO in 2020.
  • What are analysts saying about AKUS?
    Akouos Inc. has had 1 recent analyst action on file. The most recent action was from William Blair: Outperform with a $12.00 price target on 2022-09-29. Recent price targets cluster around $12.00.
  • What companies are similar to AKUS?
    Notable peers in the same industry include NPT (Texxon Holding Limited), YHGJ (Yunhong Green CTI Ltd.), CSL (Carlisle Companies Incorporated), ASH (Ashland Inc.), CLX (Clorox Company). Compare AKUS side-by-side with any of them on Quantisnow.
  • How can I track AKUS on Quantisnow?
    Quantisnow aggregates Akouos Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow AKUS to receive live email and push alerts on every new disclosure.